Perigon Wealth Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$603K Sell
9,427
-948
-9% -$62.3K 0.01% 798
2026
Q1
$739K Buy
10,375
+168
+2% +$13.2K 0.01% 630
2025
Q4
$837K Buy
10,207
+739
+8% +$57.6K 0.02% 601
2025
Q3
$711K Buy
9,468
+1,521
+19% +$113K 0.01% 615
2025
Q2
$589K Sell
7,947
-924
-10% -$64.3K 0.01% 624
2025
Q1
$716K Sell
8,871
-158
-2% -$13.6K 0.02% 529
2024
Q4
$767K Buy
9,029
+382
+4% +$32.5K 0.02% 515
2024
Q3
$812K Sell
8,647
-558
-6% -$46.8K 0.02% 486
2024
Q2
$717K Buy
9,205
+1,412
+18% +$115K 0.02% 446
2024
Q1
$708K Buy
7,793
+633
+9% +$52.7K 0.02% 456
2023
Q4
$554K Buy
7,160
+293
+4% +$20.5K 0.02% 473
2023
Q3
$467K Buy
6,867
+1,518
+28% +$110K 0.02% 458
2023
Q2
$435K Buy
5,349
+1,525
+40% +$122K 0.02% 493
2023
Q1
$314K Buy
+3,824
New +$273K 0.02% 527

Other funds holding GEHC

Perigon Wealth Management's GEHC Position: Q2 2026 in Review

Perigon Wealth Management reduced its GE HealthCare (GEHC) stake by 9.1% in Q2 2026, selling an estimated $62.3K and leaving 9,427 shares worth $603K. The position accounts for 0.01% of the portfolio, ranked #798.

Perigon Wealth Management first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $837K in Q4 2025. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Perigon Wealth Management held 9,427 shares of GE HealthCare worth $603K as of Q2 2026.
  • Perigon Wealth Management sold 948 GE HealthCare shares in Q2 2026, an estimated $62.3K.
  • GE HealthCare made up 0.01% of Perigon Wealth Management's portfolio in Q2 2026, its #798 holding.
  • Perigon Wealth Management first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Perigon Wealth Management's GE HealthCare position peaked at $837K in Q4 2025.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Perigon Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.